Histological Type‐Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan
The Laryngoscope · 2025
DOI: 10.1002/lary.32027 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Kenya Kobayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Sarcoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objective
The goal of this study was to better understand the epidemiology, clinical characteristics, and treatment outcomes of head and neck sarcomas using real‐world data from Japan.
Methods
Using the Japanese Head and Neck Cancer Registry, we identified 438 patients who were pathologically diagnosed with head and neck sarcoma between 2011 and 2020. We compared epidemiological, clinical, and prognostic data for the different histological types of sarcoma.
Results
The top five most common histopathological types were rhabdomyosarcoma, osteosarcoma, chondrosarcoma, leiomyosarcoma, and liposarcoma. The most common primary sites were the nasal cavity and paranasal sinuses. The overall cohort had clinical, pathologic, and occult lymph node positivity rate (OLR) of 18%, 15%, and 2%, respectively. Clinical lymph node positivity was highest in rhabdomyosarcoma (46%), followed by angiosarcoma (26%), with leiomyosarcoma, chondrosarcoma, and liposarcoma accounting for less than 10%. The 3‐year overall survival rate was 74.8% among the 147 patients with available prognostic information. The histological type with the lowest 3‐year overall survival was undifferentiated pleomorphic sarcoma (54%), followed by leiomyosarcoma (65%), and angiosarcoma (69%). In six of seven histological types, the 3‐year locoregional‐free survival rate was less than 70%.
Conclusion
Sarcomas of the head and neck most commonly occur in the nasal cavity and paranasal sinuses. The prevalent histological type depended on the primary site. Rhabdomyosarcoma and angiosarcoma are histological types with a high risk of cervical metastasis. In the head and neck region, there are numerous histological types many of which lack local control. Level of Evidence 3 Laryngoscope , 135:2403–2410, 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, The University of Tokyo, Tokyo, Japan.
- The Japan Society for Head and Neck Cancer, Tokyo, Japan.
- Department of Head and Neck Surgery, The National Cancer Center Hospital, Tokyo, Japan.
- Data Center Department, Clinical Study Support Center, Wakayama Medical University Hospital, Wakayama, Japan.
- Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medicine, Nagoya, Japan.
- Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
ORCID-Profile: Kenya Kobayashi, Daisuke Kawakita, Ken-Ichi Nibu, Kenji Kondo, Yuki Saito
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kobayashi, K., Yoshimoto, S., Yamamura, K., Kitayama, M., Kawakita, D., Nibu, K. I., Kondo, K., & Saito, Y. (2025). Histological Type‐Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan. The Laryngoscope. https://doi.org/10.1002/lary.32027
Vancouver
Kobayashi K, Yoshimoto S, Yamamura K, Kitayama M, Kawakita D, Nibu KI, et al. Histological Type‐Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan. The Laryngoscope. 2025. doi:10.1002/lary.32027
BibTeX
@article{Kobayashi2025,
author = {Kobayashi, Kenya and Yoshimoto, Seiichi and Yamamura, Koji and Kitayama, Megumi and Kawakita, Daisuke and Nibu, Ken-Ichi and Kondo, Kenji and Saito, Yuki},
title = {Histological Type‐Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32027}
}
EUVIMED